Option Care Health, Inc. $OPCH Shares Acquired by Geneva Capital Management LLC

Geneva Capital Management LLC lifted its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 27.6% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,369,862 shares of the company’s stock after buying an additional 296,216 shares during the period. Geneva Capital Management LLC owned approximately 0.86% of Option Care Health worth $38,027,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Durable Capital Partners LP lifted its holdings in shares of Option Care Health by 134.2% during the second quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock worth $267,557,000 after purchasing an additional 4,720,988 shares during the period. Dimensional Fund Advisors LP lifted its stake in Option Care Health by 6.6% during the 3rd quarter. Dimensional Fund Advisors LP now owns 3,796,396 shares of the company’s stock valued at $105,384,000 after acquiring an additional 235,413 shares during the period. Arrowstreet Capital Limited Partnership boosted its holdings in shares of Option Care Health by 109.0% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 3,410,394 shares of the company’s stock valued at $110,770,000 after acquiring an additional 1,778,279 shares during the last quarter. Norges Bank purchased a new stake in shares of Option Care Health in the 2nd quarter valued at $69,932,000. Finally, Swedbank AB acquired a new stake in shares of Option Care Health in the third quarter worth $49,455,000. 98.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

OPCH has been the topic of several recent research reports. Citizens Jmp reaffirmed a “market outperform” rating and issued a $38.00 price target (up from $36.00) on shares of Option Care Health in a report on Tuesday, January 13th. Weiss Ratings restated a “hold (c)” rating on shares of Option Care Health in a research note on Monday, December 29th. Wall Street Zen cut Option Care Health from a “buy” rating to a “hold” rating in a research report on Saturday, February 28th. Truist Financial set a $40.00 price target on Option Care Health in a report on Tuesday, January 13th. Finally, Jefferies Financial Group reaffirmed a “buy” rating and set a $37.00 price objective on shares of Option Care Health in a research note on Tuesday, January 13th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $37.27.

Option Care Health Price Performance

Shares of NASDAQ OPCH opened at $29.61 on Wednesday. The company has a debt-to-equity ratio of 0.87, a quick ratio of 0.96 and a current ratio of 1.53. The firm has a market cap of $4.63 billion, a PE ratio of 23.13, a PEG ratio of 1.66 and a beta of 0.85. Option Care Health, Inc. has a one year low of $24.24 and a one year high of $36.80. The firm has a fifty day moving average of $33.73 and a 200 day moving average of $30.71.

Option Care Health (NASDAQ:OPCH) last announced its earnings results on Tuesday, February 24th. The company reported $0.46 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.46. The business had revenue of $1.47 billion for the quarter, compared to analyst estimates of $1.46 billion. Option Care Health had a net margin of 3.67% and a return on equity of 18.57%. The company’s revenue for the quarter was up 8.8% compared to the same quarter last year. During the same quarter last year, the business earned $0.44 earnings per share. As a group, research analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.